Todd Smith

Mr. Todd N.
Smith is a President, Chief Executive Officer & Director at Latigo Biotherapeutics, Inc., a Chief Executive Officer at Corium LLC (Massachusetts) and a Chief Executive Officer at Corium Therapeutics Holdings LLC.
He is on the Board of Directors at Latigo Biotherapeutics, Inc., Apollo RX LLC, BVI Medical, Inc. and Beaver-Visitec International, Inc. Mr. Smith was previously employed as a President & Chief Commercial Officer by Tolmar Pharmaceuticals, Inc., a Chief Executive Officer by Valinor Pharma LLC, a President, Chief Executive Officer & Director by Assertio Therapeutics, Inc., a President, Chief Executive Officer & Director by Zyla Life Sciences LLC, a President, Chief Executive Officer & Director by Assertio Holdings, Inc., a Chief Executive Officer & Director by Iroko Pharmaceuticals, Inc., a Chief Commercial Officer & Senior Vice President by Ophthotech Corp., a Chief Commercial Officer & Executive VP by Horizon Pharma, Inc., a Senior VP-Sales, Marketing & Business Development by Horizon Therapeutics USA, Inc., a Vice President-Global Marketing & Strategy by Fenwal, Inc., and a Chief Commercial Officer & Executive VP by Horizon Pharma Plc.
He also served on the board at Vault Nano, Inc. and Bright Path Laboratories, Inc. He received his undergraduate degree from Norwich University.